Lupin has appointed Abdelaziz Toumi as CEO of its subsidiary Lupin Manufacturing Solutions to boost its contract manufacturing business for international clients. Toumi, a 20-year industry veteran, will lead the expansion of LMS's Contract Development and Manufacturing Operations business. Lupin, the third-largest pharma company in the US, has carved out a business transfer agreement with LMS.
Open FlipDabur India's management is confident about consumption revival, driven by distribution expansion, innovation, and liquidity for bolt-on acquisitions. Emkay Global has raised Dabur's share price target to ₹700 from ₹660 and maintains a 'Buy' rating. The brokerage firm sees Dabur well-placed for demand recovery, with a potential upside of 15% from the current price of ₹608.60.
Open FlipBoeing's stock has fallen over 30% in 2024, making it attractive. Despite quality control issues, Boeing's strong market position and growing industry justify its potential. The stock trades at 11.1 times FCF in 2026, a low valuation. However, labor negotiations, potential investment in cash-burning Spirit AeroSystems, and lack of a new CEO raise concerns, making Boeing a stock to avoid for now.
Open Flip